Summary
This prediction ended on 15.12.15 with a price of €112.20. With a performance of -4.06%, the BUY prediction by phonebroker finished with a loss. phonebroker has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | -4.878% | -4.878% | -57.344% | -51.498% |
| iShares Core DAX® | -1.785% | -1.250% | 11.664% | 12.714% |
| iShares Nasdaq 100 | -2.154% | 0.300% | 37.531% | 41.653% |
| iShares Nikkei 225® | -4.028% | -3.746% | 17.142% | 0.393% |
| iShares S&P 500 | -1.969% | 0.307% | 25.617% | 40.084% |
According to phonebroker what are the pros and cons of Bayer AG for the foreseeable future?
Pros
Undervalued
Cons
Risky Investment
Comments by phonebroker for this prediction
In the thread Bayer AG diskutieren
phonebroker stimmt dem Crowdsentiment von 'Buy' zu
phonebroker stimmt am 05.12.2015 dem Buy-Crowdsentiment zu.
(Vom Mitglied beendet)